InvestorsHub Logo
Followers 834
Posts 120144
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 2218

Wednesday, 05/18/2022 4:09:41 PM

Wednesday, May 18, 2022 4:09:41 PM

Post# of 3039
ENTA’s phase-2b trial in RSV misses primary endpoint:

https://ir.enanta.com/news-releases/news-release-details/enanta-pharmaceuticals-reports-topline-data-rsvp-study-edp-938

From the recent price action, it seems that this result may have been leaked.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News